Review of Biosimilar Trials and Data on Adalimumab in Rheumatoid Arthritis

被引：0
|
作者：
Sizheng Zhao
Laura Chadwick
Eduardo Mysler
Robert J. Moots
机构：
[1] University of Liverpool,Department of Musculoskeletal Biology I, Clinical Sciences Centre, Institute of Ageing and Chronic Disease
[2] Aintree University Hospital,undefined
[3] Organización Medica de Investigación,undefined
来源：
Current Rheumatology Reports | 2018年 / 20卷
关键词：
Adalimumab; Biosimilar; Rheumatoid arthritis; Amgevita; Cyltezo; Imraldi;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Adalimumab in Juvenile Rheumatoid Arthritis
    Sfriso, Paolo
    Ravaioli, Francesca
    NEW ENGLAND JOURNAL OF MEDICINE, 2008, 359 (23): : 2495 - 2495
  • [32] Adalimumab therapy in rheumatoid arthritis
    Keystone, E
    Haraoui, B
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2004, 30 (02) : 349 - +
  • [33] Adalimumab for treating rheumatoid arthritis
    Navarro-Sarabia, F
    Ariza-Ariza, R
    Hernandez-Cruz, B
    Villanueva, I
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2005, (03):
  • [34] Adalimumab in the treatment of rheumatoid arthritis
    Voulgari, Paraskevi V.
    Drosos, Alexandros A.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (04) : 549 - 561
  • [35] ETANAR - A ETANERCEPT BIOSIMILAR IS AS EFFECTIVE AS ADALIMUMAB AND INFLIXIMAB IN A COHORT OF REAL-LIFE OF PATIENTS WITH RHEUMATOID ARTHRITIS
    Santos-Moreno, P.
    Saavedra-Martinez, G.
    Villarreal, L.
    Gomez, D.
    Bello-Gualtero, J.
    Giraldo, V.
    Martinez, P.
    Sanchez, A.
    Sanchez, M.
    Uribe, E.
    Boon, M.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 789 - 790
  • [36] Usability and safety of SB5 (an adalimumab biosimilar) prefilled syringe and autoinjector in patients with rheumatoid arthritis
    Ghil, Jeehoon
    Zielinska, Agnieszka
    Lee, Younju
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (03) : 497 - 502
  • [37] REAL WORLD EXPERIENCE OF SWITCHING TO AN ADALIMUMAB BIOSIMILAR; DIFFERENT OUTCOMES FOR AXIAL SPONDYLITIS, PSORIATIC AND RHEUMATOID ARTHRITIS
    Holden, Francesca A. A.
    Hill, Diane
    Kiely, Patrick
    RHEUMATOLOGY, 2023, 62
  • [38] Population pharmacokinetics of adalimumab biosimilar adalimumab-adbm and reference product in healthy subjects and patients with rheumatoid arthritis to assess pharmacokinetic similarity
    Kang, Jia
    Eudy-Byrne, Rena J.
    Mondick, John
    Knebel, William
    Jayadeva, Girish
    Liesenfeld, Karl-Heinz
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 86 (11) : 2274 - 2285
  • [39] A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis
    Fleischmann, Roy M.
    Alten, Rieke
    Pileckyte, Margarita
    Lobello, Kasia
    Hua, Steven Y.
    Cronenberger, Carol
    Alvarez, Daniel
    Bock, Amy E.
    Sewell, K. Lea
    ARTHRITIS RESEARCH & THERAPY, 2018, 20
  • [40] A comparative clinical study of PF-06410293, a candidate adalimumab biosimilar, and adalimumab reference product (Humira®) in the treatment of active rheumatoid arthritis
    Roy M. Fleischmann
    Rieke Alten
    Margarita Pileckyte
    Kasia Lobello
    Steven Y. Hua
    Carol Cronenberger
    Daniel Alvarez
    Amy E. Bock
    K. Lea Sewell
    Arthritis Research & Therapy, 20
12345